TrialJournal for immunotherapy of cancer2018

Updated efficacy of avelumab in patients with previously treated metastatic Merkel cell carcinoma after ≥1 year of follow-up: JAVELIN Merkel 200, a phase 2 clinical trial.

Howard L Kaufman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.